Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 5197592, 10 pages
https://doi.org/10.1155/2017/5197592
Research Article

IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever

1Centro de Investigación Biomédica de Oriente, HGZ5, Instituto Mexicano del Seguro Social, Km 4.5 Carretera Atlixco-Metepec, 74360 Metepec, PUE, Mexico
2Departamento de Ciencias Químico Biológicas y Agropecuarias, División de Ciencias e Ingeniería, Universidad de Sonora, 85880 Navojoa, SON, Mexico
3Departamento de Ciencias de la Salud, Universidad Popular Autónoma del Estado de Puebla, 21 Sur 1103, 72410 Puebla, PUE, Mexico
4Hospital General de Zona No. 5, Instituto Mexicano del Seguro Social, Km 4.5 Carretera Atlixco-Metepec, 74360 Metepec, PUE, Mexico
5Laboratorio de Bioquímica y Biología Molecular, Centro de Química, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Edif. 103 F, CU-BUAP, San Manuel, 72570 Puebla, PUE, Mexico

Correspondence should be addressed to Lilian Karem Flores-Mendoza; moc.liamg@meraknailil and Julio Reyes-Leyva; moc.oohay@avyelseyerj

Received 13 March 2017; Revised 3 June 2017; Accepted 27 June 2017; Published 30 July 2017

Academic Editor: Giuseppe Valacchi

Copyright © 2017 Lilian Karem Flores-Mendoza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Gubler, “The economic burden of dengue,” The American Journal of Tropical Medicine and Hygiene, vol. 86, no. 5, pp. 743-744, 2012. View at Google Scholar
  2. M. E. Beatty, L. G. Margolis, and H. S. Phuket, ““Thailand, 2008: estimating the global burden of dengue. Abstract book: dengue”, 2008,” in Proceedings of the 2nd International Conference on Dengue and Dengue Haemorrhagic Fever. View at Publisher · View at Google Scholar · View at Scopus
  3. E. A. Undurraga, M. Betancourt-Cravioto, J. Ramos-Castaneda et al., “Economic and disease burden of dengue in Mexico,” PLoS Neglected Tropical Diseases, vol. 9, no. 3, article e0003547, 2015. View at Google Scholar
  4. WHO, Dengue Haemorrhagic Fever: Diagnosis, Treatment, and Control, World Health Organization, Geneva, 1997. View at Publisher · View at Google Scholar
  5. WHO, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, new Edition, World Health Organization, Geneva, 2009.
  6. B. E. Martina, P. Koraka, and A. D. Osterhaus, “Dengue virus pathogenesis: an integrated view,” Clinical Microbiology Reviews, vol. 22, no. 4, pp. 564–581, 2009. View at Google Scholar
  7. S. Green and A. Rothman, “Immunopathological mechanisms in dengue and dengue hemorrhagic fever,” Current Opinion in Infectious Diseases, vol. 19, no. 5, pp. 429–436, 2006. View at Google Scholar
  8. A. L. Rothman, “Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms,” Nature Reviews. Immunology, vol. 11, no. 8, pp. 532–543, 2011. View at Google Scholar
  9. Y. Kumar, C. Liang, Z. Bo, J. C. Rajapakse, E. E. Ooi, and S. R. Tannenbaum, “Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF,” PLoS Neglected Tropical Diseases, vol. 6, no. 11, article e1887, 2012. View at Google Scholar
  10. F. A. Bozza, O. G. Cruz, S. M. Zagne et al., “Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity,” BMC Infectious Diseases, vol. 8, p. 86, 2008. View at Google Scholar
  11. G. N. Malavige, L. Gomes, L. Alles et al., “Serum IL-10 as a marker of severe dengue infection,” BMC Infectious Diseases, vol. 13, no. 1, p. 341, 2013. View at Google Scholar
  12. A. R. Brasier, H. Ju, J. Garcia et al., “A three-component biomarker panel for prediction of dengue hemorrhagic fever,” The American Journal of Tropical Medicine and Hygiene, vol. 86, no. 2, pp. 341–348, 2012. View at Google Scholar
  13. T. H. Nguyen, H. Y. Lei, T. L. Nguyen et al., “Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles,” The Journal of Infectious Diseases, vol. 189, no. 2, pp. 221–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Butthep, S. Chunhakan, S. Yoksan, K. Tangnararatchakit, and A. Chuansumrit, “Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever,” The Pediatric Infectious Disease Journal, vol. 31, no. 12, pp. e232–e238, 2012. View at Google Scholar
  15. J. Arias, N. Valero, J. Mosquera et al., “Increased expression of cytokines, soluble cytokine receptors, soluble apoptosis ligand and apoptosis in dengue,” Virology, vol. 452, pp. 42–51, 2014. View at Google Scholar
  16. L. N. Akhtar and E. N. Benveniste, “Viral exploitation of host SOCS protein functions,” Journal of Virology, vol. 85, no. 5, pp. 1912–1921, 2011. View at Google Scholar
  17. W. S. Alexander and D. J. Hilton, “The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response,” Annual Review of Immunology, vol. 22, pp. 503–529, 2004. View at Google Scholar
  18. B. Carow and M. E. Rottenberg, “SOCS3, a major regulator of infection and inflammation,” Frontiers in Immunology, vol. 5, p. 58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. I. D. Dimitriou, L. Clemenza, A. J. Scotter, G. Chen, F. M. Guerra, and R. Rottapel, “Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins,” Immunological Reviews, vol. 224, pp. 265–283, 2008. View at Google Scholar
  20. S. Yokota, N. Yokosawa, T. Okabayashi et al., “Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway,” Journal of Virology, vol. 78, no. 12, pp. 6282–6286, 2004. View at Google Scholar
  21. C. M. Oshansky, T. M. Krunkosky, J. Barber, L. P. Jones, and R. A. Tripp, “Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway,” Viral Immunology, vol. 22, no. 3, pp. 147–161, 2009. View at Google Scholar
  22. J. Pothlichet, M. Chignard, and M. Si-Tahar, “Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway,” Journal of Immunology, vol. 180, no. 4, pp. 2034–2038, 2008. View at Google Scholar
  23. A. S. Collins, S. Ahmed, S. Napoletano et al., “Hepatitis C virus (HCV)-induced suppressor of cytokine signaling (SOCS) 3 regulates proinflammatory TNF-alpha responses,” Journal of Leukocyte Biology, vol. 96, no. 2, pp. 255–263, 2014. View at Google Scholar
  24. S. Ubol, W. Phuklia, S. Kalayanarooj, and N. Modhiran, “Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies,” The Journal of Infectious Diseases, vol. 201, no. 6, pp. 923–935, 2010. View at Google Scholar
  25. M. S. Rolph, A. Zaid, N. E. Rulli, and S. Mahalingam, “Downregulation of interferon-beta in antibody-dependent enhancement of dengue viral infections of human macrophages is dependent on interleukin-6,” The Journal of Infectious Diseases, vol. 204, no. 3, pp. 489–491, 2011. View at Google Scholar
  26. T. T. Tsai, Y. J. Chuang, Y. S. Lin et al., “Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes,” PLoS Neglected Tropical Diseases, vol. 8, no. 11, article e3320, 2014. View at Google Scholar
  27. R. F. Chen, K. D. Yang, I. K. Lee et al., “Augmented miR-150 expression associated with depressed SOCS1 expression involved in dengue haemorrhagic fever,” The Journal of Infection, vol. 69, no. 4, pp. 366–374, 2014. View at Google Scholar
  28. T. Estrada-Jimenez, L. Millan-Perez Pena, L. Flores-Mendoza et al., “Upregulation of the suppressors of cytokine signaling 1 and 3 is associated with arrest of phosphorylated-STAT1 nuclear importation and reduced innate response in dengue virus-infected macrophages,” Viral Immunology, vol. 29, no. 2, pp. 95–104, 2016. View at Google Scholar
  29. H. K. Palma-Ocampo, J. C. Flores-Alonso, V. Vallejo-Ruiz et al., “Interferon lambda inhibits dengue virus replication in epithelial cells,” Virology Journal, vol. 12, p. 150, 2015. View at Google Scholar
  30. P. Thakur, A. Chakravarti, S. Aggarwal, B. Uppal, and P. Bhalla, “Elevated levels of vascular endothelial growth factor in adults with severe dengue infection,” Virus Disease, vol. 27, no. 1, pp. 48–54, 2016. View at Google Scholar
  31. S. B. Halstead, “Controversies in dengue pathogenesis,” Paediatrics and International Child Health, vol. 32, Supplement 1, pp. 5–9, 2012. View at Google Scholar
  32. S. Fernando, A. Wijewickrama, L. Gomes et al., “Patterns and causes of liver involvement in acute dengue infection,” BMC Infectious Diseases, vol. 16, p. 319, 2016, 5. View at Google Scholar
  33. T. H. Lee, L. K. Lee, D. C. Lye, and Y. S. Leo, “Current management of severe dengue infection,” Expert Review of Anti-Infective Therapy, vol. 15, no. 1, pp. 67–78, 2017. View at Google Scholar
  34. A. Rathakrishnan, S. M. Wang, Y. Hu et al., “Cytokine expression profile of dengue patients at different phases of illness,” PloS One, vol. 7, no. 12, article e52215, 2012. View at Google Scholar
  35. S. Yacoub, P. K. Lam, H. M. Vu le et al., “Association of microvascular function and endothelial biomarkers with clinical outcome in dengue: an observational study,” The Journal of Infectious Diseases, vol. 214, no. 5, pp. 697–706, 2016. View at Google Scholar
  36. S. Yacoub and B. Wills, “Predicting outcome from dengue,” BMC Medicine, vol. 12, no. 1, p. 147, 2014. View at Google Scholar
  37. T. Jaenisch, D. T. Tam, N. T. Kieu et al., “Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries,” BMC Infectious Diseases, vol. 16, p. 120, 2016. View at Google Scholar
  38. M. Mahmuduzzaman, A. S. Chowdhury, D. K. Ghosh, I. M. Kabir, M. A. Rahman, and M. S. Ali, “Serum transaminase level changes in dengue fever and its correlation with disease severity,” Mymensingh Medical Journal, vol. 20, no. 3, pp. 349–355, 2011. View at Google Scholar
  39. R. Appanna, S. M. Wang, S. A. Ponnampalavanar, L. C. Lum, and S. D. Sekaran, “Cytokine factors present in dengue patient sera induces alterations of junctional proteins in human endothelial cells,” The American Journal of Tropical Medicine and Hygiene, vol. 87, no. 5, pp. 936–942, 2012. View at Google Scholar
  40. U. C. Chaturvedi, R. Agarwal, E. A. Elbishbishi, and A. S. Mustafa, “Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis,” FEMS Immunology and Medical Microbiology, vol. 28, no. 3, pp. 183–188, 2000. View at Google Scholar
  41. D. Priyadarshini, R. R. Gadia, A. Tripathy et al., “Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study,” PloS One, vol. 5, no. 1, article e8709, 2010. View at Google Scholar
  42. G. N. Malavige, L. C. Huang, M. Salimi, L. Gomes, S. D. Jayaratne, and G. S. Ogg, “Cellular and cytokine correlates of severe dengue infection,” PloS One, vol. 7, no. 11, article e50387, 2012. View at Google Scholar
  43. D. B. Bethell, K. Flobbe, X. T. Cao et al., “Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever,” The Journal of Infectious Diseases, vol. 177, no. 3, pp. 778–782, 1998. View at Google Scholar
  44. G. Levidou, S. Sachanas, G. A. Pangalis et al., “Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance,” BioMed Research International, vol. 2014, Article ID 251479, 13 pages, 2014. View at Google Scholar
  45. R. Soundravally, S. L. Hoti, S. A. Patil et al., “Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence,” International Journal of Infectious Diseases, vol. 18, pp. 68–72, 2014. View at Google Scholar
  46. S. Green, D. W. Vaughn, S. Kalayanarooj et al., “Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity,” The Journal of Infectious Diseases, vol. 179, no. 4, pp. 755–762, 1999. View at Google Scholar
  47. M. T. Fernandez-Mestre, K. Gendzekhadze, P. Rivas-Vetencourt, and Z. Layrisse, “TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients,” Tissue Antigens, vol. 64, no. 4, pp. 469–472, 2004. View at Google Scholar
  48. R. Gupta, V. Kapuria, and S. N. Das, “Single nucleotide polymorphisms in TNF-alpha, TNFR2 gene and TNF-alpha production in Asian Indians,” Immunological Investigations, vol. 38, no. 3-4, pp. 240–254, 2009. View at Google Scholar
  49. B. N. Restrepo, D. M. Isaza, C. L. Salazar, R. Ramirez, M. Ospina, and L. G. Alvarez, “Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 41, no. 1, pp. 6–10, 2008. View at Google Scholar
  50. S. Eppy, L. Nainggolan, and C. M. Rumende, “The differences between interleukin-6 and C-reactive protein levels among adult patients of dengue infection with and without plasma leakage,” Acta Medica Indonesiana, vol. 48, no. 1, pp. 3–9, 2016. View at Google Scholar
  51. B. Sierra, A. B. Perez, M. Alvarez et al., “Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus,” The American Journal of Tropical Medicine and Hygiene, vol. 87, no. 3, pp. 538–547, 2012. View at Google Scholar
  52. Y. H. Huang, H. Y. Lei, H. S. Liu, Y. S. Lin, C. C. Liu, and T. M. Yeh, “Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production,” The American Journal of Tropical Medicine and Hygiene, vol. 63, no. 1-2, pp. 71–75, 2000. View at Google Scholar
  53. L. C. Chen, H. Y. Lei, C. C. Liu et al., “Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients,” The American Journal of Tropical Medicine and Hygiene, vol. 74, no. 1, pp. 142–147, 2006. View at Google Scholar
  54. A. Ranchman and I. Rinaldi, “Coagulopathy in dengue infection and the role of interleukin-6,” Acta Medica Indonesiana, vol. 38, no. 2, pp. 105–108, 2006. View at Google Scholar
  55. M. Kubo and H. Inoue, “Suppressor of cytokine signaling 3 (SOCS3) in Th2 cells evokes Th2 cytokines, IgE, and eosinophilia,” Current Allergy and Asthma Reports, vol. 6, no. 1, pp. 32–39, 2006. View at Google Scholar
  56. D. H. Libraty, T. P. Endy, H. S. Houng et al., “Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections,” The Journal of Infectious Diseases, vol. 185, no. 9, pp. 1213–1221, 2002. View at Google Scholar
  57. C. E. Egwuagu, C. C. Y. Yu, M. Zhang, R. M. Mahdi, J. K. Stephen, and I. Gery, “Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th1 and Th2 commitment and maintenance,” The Journal of Immunology, vol. 168, pp. 3181–2187, 2002. View at Google Scholar
  58. A. Torrentes-Carvalho, C. F. Marinho, L. M. de Oliveira-Pinto et al., “Regulation of T lymphocyte apoptotic markers is associated to cell activation during the acute phase of dengue,” Immunobiology, vol. 219, no. 5, pp. 329–340, 2014. View at Google Scholar